NI
Nextech Invest
Nextech Invest is a Series A to Series D stage investment firm. It has made 9 investments. 36% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (1 deals in the last 12 months vs 2 prior). Average disclosed round size is $79.5M (across 10 rounds with reported amounts).
Portfolio
9
Fund Size
—
Top Stage
Series C
Last 12 Mo
1
Team
BC
Benjamin Cravatt
Partner
KF
Keith Flaherty
Partner
MM
Melissa McCracken
Partner
PD
Philip D Greenberg
Partner
RS
Rocco Sgobbo
Partner
TL
Thomas Lips
Partner
JT
Joanna Triscott
Associate
NB
Niresh Berinpanathan
Biotech Venture Capital
RJ
Remi Janicot
Biotech Venture Capital
SS
Sarah Soo-Hoo
Biotech Investor
TG
Thomas Geninatti
Venture Capital
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
11 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| TTubulis GmbH | Series C | — | Oct 2025 |
| AAlpha-9 Oncology, Inc. | Series C | $175M | Oct 2024 |
| AAlpha-9 | Series C | $175M | Oct 2024 |
| AAlterome Therapeutics, Inc. | Series B | $35M | Apr 2024 |
| AAlpha-9 Oncology, Inc. | Series C | $175M | Jan 2024 |
| PPMV Pharmaceuticals | Series D | $70M | Aug 2020 |
 Black Diamond | Series A | $85M | Jan 2019 |
 ImaginAb | Unknown | $8M | Oct 2017 |
| ImaginAb | Unknown | $8M | Jan 2017 |
 Tracon Pharmaceuticals | Unknown | $14M | Jan 2011 |
 Khartis Therapeutics | Series B | $50M | — |
Top Co-Investors
Frazier Life Sciences4 shared
RA Capital Management4 shared
Digitalis Ventures4 shared
Longitude Capital3 shared
Delos Capital3 shared
General Catalyst3 shared
Samsara BioCapital3 shared
Lightspeed Venture Partners3 shared
The Invus Group, LLC2 shared
Wellington Management2 shared
OrbiMed2 shared
Adage Capital Management2 shared
Raptor Group2 shared
Runway Growth Capital1 shared
JAFCO Group Co., Ltd.1 shared
New Enterprise Associates1 shared
Perceptive Advisors1 shared
Andera Partners1 shared
EQT Life Sciences1 shared
coparion1 shared
Last updated: 8 September 2026